Variant report
Variant | nsv581806 |
---|---|
Chromosome Location | chr2:49533498-49547555 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs558963676 | chr2:49533803-49533804 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs577399865 | chr2:49533811-49533812 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs541634199 | chr2:49533814-49533815 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs139334622 | chr2:49533819-49533820 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs190582731 | chr2:49533839-49533840 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs559020450 | chr2:49533840-49533841 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs551898184 | chr2:49533861-49533862 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs563726368 | chr2:49533877-49533878 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs372246305 | chr2:49533878-49533879 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs77526550 | chr2:49533880-49533881 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs183109171 | chr2:49533885-49533886 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs565027236 | chr2:49533899-49533900 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs532222670 | chr2:49534010-49534011 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs375264153 | chr2:49534036-49534037 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs547194087 | chr2:49534045-49534046 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs187886007 | chr2:49534078-49534079 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs191185404 | chr2:49534079-49534080 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs535958649 | chr2:49534098-49534099 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs534372823 | chr2:49534102-49534103 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs569661649 | chr2:49534103-49534104 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs536626388 | chr2:49534106-49534107 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs559241996 | chr2:49534140-49534141 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs552550468 | chr2:49534179-49534180 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs535288049 | chr2:49534185-49534186 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs567934978 | chr2:49534228-49534229 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs553610395 | chr2:49534251-49534252 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs150038112 | chr2:49534261-49534262 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs13006558 | chr2:49534276-49534277 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs563618567 | chr2:49534279-49534280 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs575636548 | chr2:49534283-49534284 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs545876446 | chr2:49534285-49534286 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs184660317 | chr2:49534303-49534304 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs12620389 | chr2:49534329-49534330 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs551379936 | chr2:49534357-49534358 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs547255328 | chr2:49534392-49534393 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs187932667 | chr2:49534432-49534433 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs111811114 | chr2:49534472-49534473 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs112561293 | chr2:49534475-49534476 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs559154096 | chr2:49534503-49534504 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs529816712 | chr2:49534524-49534525 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs575172339 | chr2:49534566-49534567 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs376061259 | chr2:49534610-49534611 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs548300330 | chr2:49534619-49534620 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs397787678 | chr2:49534620-49534621 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs569640252 | chr2:49534719-49534720 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs537096500 | chr2:49534729-49534730 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs544141454 | chr2:49534732-49534733 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs6733758 | chr2:49534736-49534737 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs541510348 | chr2:49534740-49534741 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs180966335 | chr2:49545010-49545011 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Bladder cancer | 21909424 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 17297452 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 20433910 | CNVD |
Autism | 21701786 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 20553308 | CNVD |
Autism | 22241247 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Mental retardation | 19521722 | CNVD |
Schizophrenia | 18990708 | CNVD |
Schizophrenia | 18940311 | CNVD |
Schizophrenia | 19348701 | CNVD |
Schizophrenia | 18945720 | CNVD |
Schizophrenia | 19571808 | CNVD |
Prostate cancer | 16573809 | CNVD |
Neuroticism | 17667963 | CNVD |
Schizophrenia | 19443537 | CNVD |
Schizophrenia | 19546859 | CNVD |
Autism | 17322880 | CNVD |
Lung cancer | 17086460 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:49533800-49534400 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
2 | chr2:49533800-49534400 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
3 | chr2:49533800-49534800 | Enhancers | HUVEC | blood vessel |
4 | chr2:49534000-49534400 | Enhancers | Pancreatic Islets | Pancreatic Islet |
5 | chr2:49534000-49534600 | Enhancers | HepG2 | liver |
6 | chr2:49545000-49545400 | Enhancers | HUES48 Cell Line | embryonic stem cell |